Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) Drugs In Development, 2022 Update

by Stages, Target, MoA, RoA, Molecule Type and Key Players

Published	Pages	Publisher	Report code
Feb 2022	44	Global Markets Direct	ASDR-597972

Published: Feb 2022 - Pages : 44 - Publisher : Global Markets Direct - Report code : ASDR-597972

Amgen Inc
Incyte Corp
Inflection Biosciences Ltd
NewBay Medical Technology Co Ltd
Novartis AG
Sanofi
Sumitomo Dainippon Pharma Oncology
Inc
Yakult Honsha Co Ltd
Zovis Pharmaceuticals

RAF Proto Oncogene SerineThreonine Protein Kinase - Pipeline Review, H2 2019

This report can be of interest as well:

RAF Proto Oncogene SerineThreonine Protein Kinase - Pipeline Review, H2 2019

Published: December, 2019 | Report code: ASDR-503230